CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

J Clin Invest. 2024 May 1;134(9):e181576. doi: 10.1172/JCI181576.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Published Erratum